Cytori Therapeutics (CYTX) Updates on ATHENA Trials; Two non-Cell-Related Fatal Events Reported
Tweet Send to a Friend
Cytori Therapeutics, Inc. (Nasdaq: CYTX) announced the presentation of six and twelve month data from the ATHENA Trials at the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
